Avextra AG, a vertically-integrated manufacturer of cannabis-based medicines located in Germany, announced the export of its standardised cannabis extracts to Italy.

Italy is a key market for Avextra, with the second-largest patient population for cannabis-based medicines in the European Union. Avextra is one of only three companies approved to import cannabis medicines into the country. According to the company in Italy over 70% of the …

Full story available on Benzinga.com

A note to our visitors

This website has updated its privacy policy in compliance with changes to European Union data protection law, for all members globally. We’ve also updated our Privacy Policy to give you more information about your rights and responsibilities with respect to your privacy and personal information. Please read this to review the updates about which cookies we use and what information we collect on our site. By continuing to use this site, you are agreeing to our updated privacy policy.